• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Alexion Pharmaceuticals

Alexion Pharmaceuticals

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. BioSpecifics Technologies Corp. Reports Second Quarter 2014 Financial Results

    BioSpecifics Technologies Corp. Reports Second Quarter 2014 Financial Results

  2. European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG)

    European Commission Grants Orphan Drug Designation to Soliris® (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG)

  3. Medalist Funds Like These Large-Cap Stocks

    We crunch the numbers to see which stocks are most widely held among analyst-recommended large-cap funds.

  4. Which Funds Own My Stock?

    Ownership data provide a look at who else owns the company.

  5. Our 5 Nominees for Domestic-Stock Fund Manager of the Year

    Standing out in a good year for stocks.

  6. Morningstar Indexes: Weekly Market Report

    Week ending Nov. 10: Investors remain optimistic about direction of economy.

  7. How to Avoid Unpleasant Surprises

    Buying a country or sector fund isn't as easy as it seems.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.